Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T19:53:00.876Z.
Calculation as of: 2026-10-06T19:53:00.876Z.
Quote observation: 2026-10-06T19:50:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f522eee919378f7ead273ce64f9b652ac6d8ba1380de8c5eb79fdcf7ed4dc2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$30.43M
EV/EBIT Ratio
N/A
TTM Avg
85.48x
3Y Avg
85.48x
5Y Avg
85.48x
Market Cap
$31.44M
EV/EBIT Ratio
19.06x
TTM Avg
29.28x
3Y Avg
15.24x
5Y Avg
15.09x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MDxHealth S.A. (MDXH) | $30.82M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.31M | N/A | 0.97x | 0.97x | 0.97x |
| CervoMed Inc. (CRVO)vs › | $30.44M | N/A | 0.37x | 0.82x | 0.82x |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.42M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $30.43M | N/A | 85.48x | 85.48x | 85.48x |
| BeyondSpring Inc. (BYSI)vs › | $29.89M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 19.06x | 29.28x | 15.24x | 15.09x |
| Context Therapeutics Inc. (CNTX)vs › | $29.37M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.63M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
